BSX Q1 2024 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.9B+13.8% YoY

Gross Profit

$2.4B61.8% margin

Operating Income

$644M16.7% margin

Net Income

$494M12.8% margin

EPS (Diluted)

$0.33

QoQ Revenue Growth

+3.5%

Cash Flow

Operating Cash Flow

$164M

Free Cash Flow

-$81M

Stock-Based Comp.

$63M

Balance Sheet

Total Assets

$36.7B

Total Liabilities

$16.5B

Stockholders' Equity

$19.9B

Cash & Equivalents

$2.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.9B	$3.4B	+13.8%
Gross Profit	$2.4B	$2.1B	+14.8%
Operating Income	$644M	$515M	+25.0%
Net Income	$494M	$314M	+57.3%

Revenue Segments

Cardiovascular

$2.4B63%

MedSurg

$1.4B37%

Geographic Segments

UNITED STATES

$2.3B59%

Non-US

$1.6B41%